Clinical Trial Detail

NCT ID NCT02004106
Title A Study of RO6895882 in Patients With Advanced and/or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche

lung non-small cell carcinoma

colorectal cancer

Advanced Solid Tumor

head and neck cancer


Cergutuzumab amunaleukin

Age Groups: adult

No variant requirements are available.